İnfektif endokarditten Korunma Kılavuzu

KAYNAKLAR

    1. Sandre RM, Shafran SD. Infective endocarditis: Review of 135 cases over 9 years. Clin Infect Dis 1996; 22: 276-86
    2. Hall G, Heimdahl A, Nord CE. Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis. Clin Infect Dis 1999; 29: 1-10
    3. Mortara LA, Bayer AS. Staphylococcus aureus bacteremia and endocarditis: New diagnostic and therapeutic concepts. Infect Dis Clin North Am 1993; 7: 53-68
    4. Dajani AS, Taubert KA, Wilson W et al. Prevention of bacterial endocarditis: Recommendations by the American Heart Association. Clin Infect Dis 1997; 25: 1448-58
    5. Jurado RL, Klein S. Infective endocarditis associated with fiberoptic bronchoscopy in in a patient with mitral valve prolapse. Clin Infect Dis 1998; 26: 768-9
    6. Mani V, Cartwright K, Dooley J, Swarbrick E, Fairclough P, Oakley C. Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee. Endoscopy 1997; 29: 114-9
    7. Ho H, Zuckerman M, Wassem C. A prospective controlled study of the risk of bacteremia in emergency sclerotherapy of esophageal varices. Gastroenterology 1991; 101: 1642-48
    8. Rey JR, Axon A, Budzynski A, Kruse A, Nowak A. Guidelines of the European Society of Gastrointestinal Endoscopy (ESGE): Antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy 1998; 30: 318-24
    9. Subhani JM, Kibbler, Dooley JS. Antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 1999; 13: 103-16
    10. Leport C and the Endocarditis Working Group of the International Society of Chemotherapy. Antibiotic prophylaxis for infective endocarditis. Clin Microbiol Infect 1998; 4: 3S56-3S61
    11. Durack DT. Prevention of infective endocarditis. N Engl J Med 1995; 332: 38-44
    12. DeGevigney G, Pop C, Delahaye JP. The risk of infective endocarditis after cardiac surgical and interventional procedures. Eur Heart J 1995; 16 (Suppl B): 7-14
    13. DaCosta A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz K, Touboul P. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998; 97: 1796-1801
    14. Skeckelberg JM, Wison WR. Risk factors for infective endocarditis. Infect Dis Clin North Am. 1993; 7: 9-19
    15. Dajani As, Taubert KA, Wilson, Bolger A, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallash TJ, Gage TW, Levison ME, Petr G, Zuccaro G. Preventetion of bacterial endocarditis. Circulation 1997; 96: 358-366
    16. David T, Durack MB. Preventetion of infective endocarditis. N Engl J Med. 332: 38-43
    17. Bonow RO, et al: ACC/AHA Guidelines for Management of Patient With Valvular heart Disease. J A Coll Cardiol 1998; 32 (5): 1486-588
    18. Saiman I, Prince A, Gersony WM. Padiatric infective endocarditis in the modern era. J Pediatr 1993; 122: 847-853
    19. Prabhu SD, O’ Rourke RA. Mitral valv prolaps. In: Braunwald E, series ed. Rahimtoola SH, volüm ed. Atlas of Heart Disease: Valvular heart disease: Vol X. St Louis Mo: Mosby Year Book Inc; 1997; 10.1-10.18
    20. Devereux RB, Frary Cj, Kramer-Fox R, Roberts RII, Ruchlin HS. Cost effectiveness of infective endocarditis prophylaxis for mitral regurgitant murmur. Am J Cardiol. 1995; 75: 1028-1032
    21. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: A Report of American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Circulation, 1997; 95: 1686-1744
    22. Bonnow RO, Carbello B, de Leon AC Jr, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: A Report of American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 1998; 32: 1486-588
    23. British Society for Antimicrobial Chemotherapy. Antibiotic prophylaxis of infective endocarditis. Recommendations from Endocarditis Working Party of British Society for Antimicrobial Chemotherapy. Lancet 1990; 335: 88-89.
    24. Dajani AS, Bawdon RE, Berry MC. Oral amoxisilin as proflaxis for endocarditis: What is the optimal dose? Clin Infect Dis 1994; 18: 157-160.
    25. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Clin Infect Dis 1997; 25: 1448-1458.
    26. Durack DT. Prevention of bacterial endocarditis. N Engl J Med 1995; 332: 38-44.
    27. Durack DT. Antibiotics for prevention of endocarditis during dentistry: Time to scale back? Ann Intern Med 1998; 129: 829-831.
    28. Frank UK, Gersıny WM, Hayes CJ, Driscoll DJ, et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis or ventricular septal deffect. Circulation 1993; 87 (suply I): 121-126.
    29. Frank UK, Schimidt-Eisenlohr E, Mlangeni D, et al. Penetration of teicoplanin into heart valves and subcutaneus and muscle tissues of patients undergoing open-heart surgery. Antimicrob Agents Chemether 1997; 41: 2559-61.
    30. Perdikaris GS, Pefanis A, Giamarellou H, et al. Successful single-dose teicoplanin prophylaxis against experimantal streptococcal, enterococcal, and staphylococcal aortic valve endocarditis. Antimicrob Agents Chemether 1997; 41: 1916-21.
    31. Simmons NA, Ball AP, Cawson RA, et al. Antibiotic prophylaxis and infective endocarditis. Lancet 1992; 339: 1292-3.
    32. Strom BL, Abrutyn E, Berlin JA. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med 1998; 129: 761-69.
    33. The Endocarditis Working Party for Antimicrobial Chemotherapy. Recommendation for endocarditis prophylaxis. J Antimicrob Chemother 1993; 31: 437-38.
    34. Van der Meer JT Van Wijk W, Thompson J, Valkenburg HA, Michel MF. Awareness of need and actual use of prophylaxis: role of patient compliance in the prevention of bacterial endocarditis. J Antimicrob Chemother 1992; 29: 187-94.